Health Wizz uses blockchain to protect health information on mobile platforms

Health Wizz have launched a mobile platform with blockchain technology to provide patients a secure platform to aggregate, organize and share personal health records.

At times, healthcare has appeared unprepared in its adjustment to developing technology. Electronic health records (EHRs) have become a target for hackers to sell on the black market. Health Wizz’s mobile platform uses blockchain technology to protect data and give patients an ability to control the sharing of medical information.

"Medical records and data management are some of the greatest impediments to quality health care," said Nitin Desai, MD, chief medical officer of Health Wizz. "We have seen medical health record inaccuracies, data integration problems and privacy concerns in regards to the buying and selling of personal data. Your health is your greatest asset. Your health data records are your second greatest asset. We believe that people must be in control of their health records. It is your body, your data."

Through the use of blockchain technology, patients are able to use a type of cryptocurrency as an incentive to filling out health data for research and precision medicine. Additionally, those asking for patient health data must “purchase” the data using cryptocurrency. These exchanges of data through the mobile app are secured by blockchain for safe organization and sharing of data.

"Dubbed the most innovative technology since the Internet, blockchain eliminates the middleman between the patient and his or her medical health records. We've developed a platform based on blockchain, data management and mobile technologies that shifts the locus of control from medical institutions back to the patient, enabling people to take control of their own data,” said Sirish Bajpai, chief technology officer of Health Wizz. "Health Wizz doesn't store health records on the blockchain. It stores a signature of the record on a blockchain and provides secure access to the patient, who is ultimately in control of when, where, how and who can access that record. This digital signature also assures the integrity of the record.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.